Fatty acid interactions with genetic polymorphisms for cardiovascular disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 2, 2010, Pages 139-144

  Smith, Caren E ^a   Ordovás, José M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Fatty acids; Nutrientgene interactions

Indexed keywords

MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR 7 LIKE 2;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; FAT INTAKE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; INFLAMMATION; LIPID METABOLISM; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRIENT GENE INTERACTION; NUTRITION; OBESITY; POSTPRANDIAL STATE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; DIETARY FATS; FATTY ACIDS; FATTY LIVER; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; NUTRIGENOMICS; OBESITY; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 76749160292     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283357287     Document Type: Review

References (45)

1. Martinelli N, Girelli D, Malerba G, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are asso ciated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-949.
2. Allayee H, Baylin A, Hartiala J, et al. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr 2008; 88: 934-940.
3. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350:29-37.
4. Gonzalez P, RegueroJR, LozanoI, et al. Afunctional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction. Int J Immunogenet 2007; 34:127-130.
5. Lindi V, Schwab U, Louheranta A, et al. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: the KANWU study. Nutr Metab Cardiovasc Dis 2008; 18:88-95.
6. Perez-Martinez P, Lopez-Miranda J, Cruz-Teno C, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr 2008; 138:1609-1614.
7. Goyenechea E, Collins LJ, Parra D, et al. CD36 gene promoter polymorphisms are associated with low density lipoprotein-cholesterol in normal twins and after a low-calorie diet in obese subjects. Twin Res Hum Genet 2008; 11:621-628.
8. Tai ES, Corella D, Demissie S, et al. Polyunsaturated fatty acids interact with the PPARA-L162 V polymorphism to affect plasma triglyceride and apolipo-protein C-III concentrations in the Framingham Heart Study. J Nutr 2005; 135:397-403.
9. Volcik KA, Nettleton JA, Ballantyne CM, et al. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2008; 87:1926-1931.
10. Madden J, Carrero JJ, Brunner A, et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008; 78:327-335.
11. Ma X, Bacci S, Mlynarski W, et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Gen 2004; 13:2197-2205.
12. Rubin D, Helwig U, Nothnagel M, et al. Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with-11388 promoter polymorphism. Br J Nutr 2008; 99:76-82.
13. Jimenez-Gomez Y, Perez-Jimenez F, Marin C, et al. The-250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. Nutr Metab Cardiovasc Dis 2008; 18: 173-181.
14. Gomez P, Miranda JL, Marin C, etal. Influence of the-514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism. Atherosclerosis 2004; 174:73-79. (Pubitemid 38595442)
15. Kimber CH, Doney AS, Pearson ER, et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007; 50:1186-1191.
16. Melzer D, Murray A, Hurst AJ, et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 2006; 4: 34.
17. Warodomwichit D, Arnett DK, Kabagambe EK, et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J Nutr 2009; 139:439-446.
18. Zeman M, Vecka M, Jachymova M, et al. Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression. Tohoku J Exp Med 2009; 217:287-293.
19. Koletzko B, Demmelmair H, Schaeffer L, et al. Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements. Nestle Nutrition Workshop Series. Paediatric Programme 2008; 62:35-44; discussion 44-49
20. Malerba G, Schaeffer L, Xumerle L, etal. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43:289-299.
21. Franks PW, Scheele C, Loos RJ, etal. Genomic variants at the PINK1 locus are associated with transcript abundance and plasma nonesterified fatty acid concentrations in European whites. FASEB J 2008; 22:3135-3145.
22. Bendlova B, Vejrazkova D, Vcelak J, et al. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2. Physiol Res 2008; 57 (Suppl 1):S77-S90.
23. Ward NC, Tsai IJ, Barden A, et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension 2008; 51:1393-1 398.
24. Tanaka T, Shen J, Abecasis GR, et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009; 5:e1000338.
25. de Luis DA, Aller R, IzaolaO, etal. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary, to two hypocaloric diets: a randomized clinical trial. Diabetes Res Clin Pract 2008; 82:113-118.
26. de Luis DA, Aller R, Izaola O, et al. Influence of Lys656Asn polymorphism of leptin receptor gene on leptin response secondary to two hypocaloric diets: a randomized clinical trial. Ann Nutr Metab 2008; 52:209-214.
27. Kourlaba G, Pitsiladis YP, Lagou V, et al. Interaction effects between total energy and macronutrient intakes and angiotensin-converting enzyme 1 (ACE) I/D polymorphism on adiposity-related phenotypes in toddlers and preschoolers: the Growth, Exercise and Nutrition Epidemiological Study in preschoolers (GENESIS). Br J Nutr 2008; 100:1333-1340.
28. Timpson NJ, Emmett PM, Frayling TM, et al. The fat mass-and obesity-associated locus and dietary intake in children. Am J Clin Nutr 2008; 88:971-978.
29. Qi L, Kraft P, Hunter DJ, et al. The common obesity variant near MC4Rgene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet 2008; 17:3502-3508.
30. Warodomwichit D, Shen J, Arnett DK, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity 2009;17:510-517.
31. Lai C-Q, Parnell LD, Arnett DK, et al. WDTC1, the ortholog of Drosophilaadipose gene, associates with human obesity, modulated by MUFA intake.Obesity 2009; 17:593-600.
32. Enhorning S, Leosdottir M, Wallstrom P, et al. Relation between human vasopressin 1a gene variance, fat intake, and diabetes. Am J Clin Nutr 2009; 89:400-406.
33. Zak A, Jachymova M, Tvrzicka E, et al. The influence of polymorphism of-493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. J Nutr Biochem 2008; 19:634-641.
34. Junyent M, Arnett DK, Tsai MY, et al. Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women. J Nutr 2009; 139:842-848.
35. Truong H, DiBello JR, Ruiz-Narvaez E, et al. Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? Am J Clin Nutr 2009; 89:920-925.
36. Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. Alpha-Linolenic acid, delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am J Clin Nutr 2007; 85:554-560.
37. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459-469.
38. Perez-Martinez P, Corella D, Shen J, et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene poly morphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr 2009; 89:391-399.
39. Ylonen SK, Salminen I, Lyssenko V, et al. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr 2008; 62:1432-1439.
40. Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 2008; 99:168-174.
41. Gonzalez Sanchez JL, Serrano Rios M, Fernandez Perez C, et al. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 2002; 147:495-501.
42. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn study. Atherosclerosis 2007; 191:391-396.
43. Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42:1175-1183.
44. Musso G, Gambino R, De Michieli F, et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH. Hepatology 2008; 47:1167-1177.
45. Musso G, Gambino R, Pacini G, et al. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysre-gulated enteroadipocyte axis as a novel feature of fatty liver. Am J Clin Nutr 2009; 89:558-567.